SafeHeal
SafeHeal is a leading innovator in the field of digestive surgery. Its CE-marked Colovac device is a unique endoluminal bypass sheath placed in the colon following colorectal resection. It suppresses the contact of fecal content with the colorectal anastomotic site in order to significantly improve patient recovery after colorectal surgery, without the need for an ostomy. It is seamless, minimally invasive and fully reversible. It can remain in place until the body’s natural healing and tissue repair processes are complete.
Sector
Medical Devices
Strategies
MD Start & Capital
Status
Live
Website
www.safeheal.com
Antoine Papiernik
Chairman & Managing Partner, Sofinnova Partners
Anne Osdoit
Partner, Sofinnova Partners - MD Start Strategy
Related News
SafeHeal Receives Breakthrough Device designation for Colovac Endoluminal Bypass Sheath
SafeHeal appoints medical device industry veteran Chris Richardson as Chief Executive Officer
SafeHeal announces successful launch of pivotal study for Colovac endoluminal bypass sheath
SafeHeal closes €40 million financing co-led by Sofinnova Partners and Genesis MedTech to finance its Colovac device through a pivotal clinical trial in the United States
SafeHeal obtains CE-mark for Colovac, its novel endoluminal bypass sheath
SofinnovaCapital
The Sofinnova Capital Strategy acts as a founding and lead investor in early-stage biopharma and medtech start-ups focusing on groundbreaking therapeutic technologies.
SofinnovaMD Start
The MD Start Strategy is Sofinnova’s in-house medtech accelerator. The team’s hands-on entrepreneurial expertise contributes to the platform's global leadership in company building.
SofinnovaCrossover
The Sofinnova Crossover Strategy supports ground-breaking innovations in later-stage biotech and medtech companies, enabling ambitious life sciences companies to reach their full potential.
SofinnovaIndustrial Biotech
Our Industrial Biotech Strategy seeks early-stage investments that will have a positive impact on sustainability in the chemicals, agriculture, food and materials sectors.
SofinnovaTelethon
The Sofinnova Telethon Strategy seeks early-stage projects to bring the best Italian science to the world stage.
SofinnovaDigital Medicine
The Sofinnova Digital Medicine Strategy backs early-stage startups at the intersection of biology, data and computation.
SofinnovaBiovelocita
The Sofinnova Biovelocita Strategy is dedicated entirely to the creation and acceleration of European biotech startups, in partnership with leading research organizations.